We came across a bullish thesis on The Cigna Group (CI) on Antonio Linares’ Substack. In this article, we will summarize the ...

It comes as the mayor is already facing scrutiny from Ogles and other Republicans for his handling of the ICE operations.

Onesource Specialty, a newly demerged pharma CDMO, is set to benefit from the $150 billion GLP-1 weight-loss drug boom with ...

BioAge Labs, Inc. (NASDAQ:BIOA), a clinical-stage biotech innovator, announced today the completion of IND-enabling studies ...

Many of us have been personally affected by cancer — including me. I’m an oncologist, and my own family history is one of the ...

MEDVi, an online hub for GLP-1 drugs, wants you to know that it's "serious" about helping you lose weight. According to its ...

Explore the evolving landscape of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) for obesity, highlighting access ...

After the slimming effect of Ozempic and Zepbound earned billions for Novo Nordisk and Eli Lilly, another class of ...

Newly updated stroke prevention guidelines say women with endometriosis and women with early-onset menopause are at greater ...

The stocks of The Coca-Cola Company (NYSE: KO) and PepsiCo (NASDAQ: PEP ). Inc. are a source of debate between value and growth investors. In 2025, KO stock clearly holds the upper hand. The stock is ...

For adults with diabetes and obesity, glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are associated with a reduced risk for obesity-related cancer compared with dipeptidyl peptidase-4 (DPP-4) ...